Founded in 2016, NovaSight has experienced rapid growth by delivering end-to-end eye-tracking-based vision care solutions. The company focuses on three major verticals: vision treatment, vision diagnostics and prevention and monitoring of visual health conditions.
The CureSight™ is an FDA cleared and CE marked eye tracking-based system for treatment of lazy eye designed to replace the traditional eye patching. CureSight trains the visual system to use both eyes simultaneously, by blurring the center of vision of the image that is shown to the strong eye while the user watches any streamed video content of choice in the comfort of his home.
With 3 unique CPT codes for its technology and excellent clinical outcomes published in the industry’s leading peer reviewed journal, NovaSight has already launched CureSight in the US.
Another NovaSight product is the EyeSwift®PRO system – a CE marked comprehensive vision diagnostics device which provides fast, accurate, and objective measurements of multiple visual performances as well as lenses’ recommendations.
In addition, NovaSight’s pipeline products include the TrackSight™ – a software solution that monitors real-time visual health and promotes myopia prevention when using screens.
Backed by venture capital and strategic partners, NovaSight had raised to date $26M and is in the midst of a $25M B round.